Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse
- 15 October 2010
- journal article
- Published by Elsevier BV in Cancer Genetics and Cytogenetics
- Vol. 202 (2), 101-107
- https://doi.org/10.1016/j.cancergencyto.2010.07.117
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic LeukemiaScience, 2008
- DNA profiling by arrayCGH in acute myeloid leukemia and myelodysplastic syndromesCytogenetic and Genome Research, 2007
- Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemiaLeukemia, 2007
- Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First RelapseJournal of Clinical Oncology, 2005
- Precursor B Lymphoblastic Leukemia With Surface Light Chain Immunoglobulin RestrictionAmerican Journal of Clinical Pathology, 2004
- Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2003
- Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)Blood, 2002
- Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapyLeukemia, 2002
- The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 TrialBlood, 1998
- Cytogenetic studies of 103 patients with acute myelogenous leukemia in relapseCancer Genetics and Cytogenetics, 1989